NEYROTEX
Pharmaceutical form: Solution for intravenous and intramuscular administration
Composition: 1 ampoule (2 ml) contains ethylmethylhydroxypyridine succinate as an active substance – 100 mg; 1 ampoule (5 ml) contains ethylmethylhydroxypyridine succinate as an active substance – 250 mg;
Pharmacotherapeutic group: antioxidant agent
